Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
46
NMFC Quote, Financials, Valuation and Earnings
Last price:
$11.09
Seasonality move
:
-2.98%
Day range:
$11.14 - $11.48
52-week range:
$10.62 - $13.10
Dividend yield:
12.16%
P/E ratio:
10.73x
P/S ratio:
11.19x
P/B ratio:
0.89x
Volume:
2.2M
Avg. volume:
547.4K
1-year change:
-12.7%
Market cap:
$1.2B
Revenue:
$143.7M
EPS (TTM):
$1.05
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $109.1M | $56.9M | $203.6M | $89.1M | $143.7M | |
| Revenue Growth (YoY) | 43.94% | -47.86% | 257.9% | -56.25% | 61.27% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.9M | $9.8M | $9.6M | $9.9M | $9.9M | |
| Other Inc / (Exp) | $890K | -$2.8M | -$3.9M | $52.7M | -$32.9M | |
| Operating Expenses | -$3.4M | -$3.9M | -$3.8M | $5.3M | $5.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $112.6M | $60.8M | $207.4M | $83.8M | $137.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$991K | $232K | $9.3M | $1.8M | |
| Net Income to Company | $112.6M | $61.8M | $207.2M | $74.5M | $136.1M | |
| Minority Interest in Earnings | -- | -$3.4M | -$5.8M | $204K | -$747K | |
| Net Income to Common Excl Extra Items | $112.6M | $58.5M | $201.4M | $74.7M | $135.3M | |
| Basic EPS (Cont. Ops) | $1.32 | $0.60 | $2.08 | $0.75 | $1.34 | |
| Diluted EPS (Cont. Ops) | $1.22 | $0.60 | $1.91 | $0.74 | $1.24 | |
| Weighted Average Basic Share | $85.2M | $96.8M | $97M | $100.2M | $101.1M | |
| Weighted Average Diluted Share | $100.5M | $110.1M | $110.2M | $115.4M | $123.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $196.9M | $138.9M | $280.5M | $176.2M | $262.6M | |
| Revenue (Reported) | $109.1M | $56.9M | $203.6M | $89.1M | $143.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $196.9M | $138.9M | $280.5M | $176.2M | $262.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $87.7M | $21.6M | $8.6M | $29.2M | $26.7M | |
| Revenue Growth (YoY) | 293.65% | -75.33% | -60.46% | 240.72% | -8.46% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2M | $2.5M | $2.2M | $2.4M | $2.6M | |
| Other Inc / (Exp) | $47K | $23M | -$222K | $4.7M | -$531K | |
| Operating Expenses | -$1.7M | -$1.3M | $1.1M | $1.4M | $1.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $89.5M | $22.9M | $7.5M | $27.8M | $25M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$134K | -$9K | -$43K | -$918K | $1.2M | |
| Net Income to Company | $89.6M | $22.9M | $7.5M | $28.7M | $23.9M | |
| Minority Interest in Earnings | -$1.4M | -$1.1M | $191K | -$3K | -$5K | |
| Net Income to Common Excl Extra Items | $88.2M | $21.8M | $7.7M | $28.7M | $23.9M | |
| Basic EPS (Cont. Ops) | $0.91 | $0.23 | $0.08 | $0.28 | $0.22 | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.22 | $0.08 | $0.27 | $0.22 | |
| Weighted Average Basic Share | $96.8M | $96.9M | $100.8M | $101M | $107.9M | |
| Weighted Average Diluted Share | $110.1M | $110.2M | $114.1M | $123.2M | $126.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $107.5M | $40.6M | $32.1M | $59.2M | $62.7M | |
| Revenue (Reported) | $87.7M | $21.6M | $8.6M | $29.2M | $26.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $107.5M | $40.6M | $32.1M | $59.2M | $62.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13M | $213.9M | $117M | $138.9M | $124.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.3M | $9.6M | $9.6M | $10.2M | $10.5M | |
| Other Inc / (Exp) | -$3.2M | $13.5M | $18.9M | $25.1M | -$84.3M | |
| Operating Expenses | -$1.8M | -$7.8M | $3.9M | $5.9M | $6.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14.8M | $221.7M | $113.2M | $132.9M | $117.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$554K | -$200K | $225K | $9.5M | $3.6M | |
| Net Income to Company | $15.3M | $221.9M | $112.9M | $123.4M | $114.3M | |
| Minority Interest in Earnings | -$1.6M | -$6.6M | -$844K | -$436K | -$1.3M | |
| Net Income to Common Excl Extra Items | $13.8M | $215.3M | $112.1M | $123M | $113M | |
| Basic EPS (Cont. Ops) | $0.13 | $2.22 | $1.15 | $1.22 | $1.07 | |
| Diluted EPS (Cont. Ops) | -$0.03 | $2.10 | $1.07 | $1.14 | $1.05 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $98.7M | $294M | $195.3M | $255.3M | $250.5M | |
| Revenue (Reported) | $13M | $213.9M | $117M | $138.9M | $124.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $98.7M | $294M | $195.3M | $255.3M | $250.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -$7M | $149.9M | $63.3M | $113.1M | $94.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.3M | $7.1M | $7.1M | $7.4M | $7.9M | |
| Other Inc / (Exp) | -$3.6M | $12.7M | $35.5M | $7.9M | -$43.5M | |
| Operating Expenses | -$282K | -$4.1M | $3.5M | $4.2M | $5.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.8M | $154.1M | $59.8M | $108.9M | $88.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$662K | $129K | $122K | $335K | $2.2M | |
| Net Income to Company | -$6.1M | $153.9M | $59.7M | $108.6M | $86.8M | |
| Minority Interest in Earnings | -$1.6M | -$4.8M | $150K | -$490K | -$994K | |
| Net Income to Common Excl Extra Items | -$7.7M | $149.1M | $59.9M | $108.1M | $85.8M | |
| Basic EPS (Cont. Ops) | -$0.08 | $1.54 | $0.61 | $1.07 | $0.80 | |
| Diluted EPS (Cont. Ops) | -$0.24 | $1.42 | $0.58 | $0.99 | $0.79 | |
| Weighted Average Basic Share | $290.5M | $290.6M | $299.8M | $302.8M | $318.4M | |
| Weighted Average Diluted Share | $330.3M | $330.3M | $339.6M | $373.8M | $375M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $54.5M | $209M | $123.8M | $202.8M | $190.7M | |
| Revenue (Reported) | -$7M | $149.9M | $63.3M | $113.1M | $94.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $54.5M | $209M | $123.8M | $202.8M | $190.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $48.6M | $79M | $58.1M | $71.2M | $70.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $80.7M | $116.5M | $88.9M | $107.3M | $114.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $3.2B | $3B | $3.2B | $3.2B | $3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.3B | $3.1B | $3.3B | $3.4B | $3.2B | |
| Accounts Payable | $18.3M | $42.4M | $25.3M | $19.6M | $20.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $36.9M | $61.1M | $43.5M | $36.5M | $39.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $1.9B | $2B | $2B | $1.8B | |
| Common Stock | $968K | $968K | $979K | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.3B | $1.2B | $1.3B | $1.3B | $1.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $15M | $21.4M | $11.7M | $11.8M | |
| Total Equity | $1.3B | $1.2B | $1.3B | $1.3B | $1.3B | |
| Total Liabilities and Equity | $3.3B | $3.1B | $3.3B | $3.4B | $3.2B | |
| Cash and Short Terms | $48.6M | $79M | $58.1M | $71.2M | $70.1M | |
| Total Debt | $1.9B | $1.8B | $1.9B | $2B | $1.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $68.7M | $83.4M | $48.9M | $83.3M | $61.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $107.2M | $125.1M | $82.8M | $128.9M | $116.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $2.9B | $3B | $3.2B | $3.1B | $3.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3B | $3.2B | $3.3B | $3.3B | $3.4B | |
| Accounts Payable | $10.1M | $34.2M | $12.2M | $27.9M | $28.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $44.8M | $52.2M | $31.3M | $48.6M | $48.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.8B | $1.9B | $2B | $1.9B | $2B | |
| Common Stock | $968K | $969K | $1M | $1M | $1.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $12.4M | $20.1M | $13.1M | $11.7M | $6.3M | |
| Total Equity | $1.2B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Total Liabilities and Equity | $3B | $3.2B | $3.3B | $3.3B | $3.4B | |
| Cash and Short Terms | $68.7M | $83.4M | $48.9M | $83.3M | $61.9M | |
| Total Debt | $1.8B | $1.8B | $2B | $1.9B | $2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $112.6M | $61.8M | $207.2M | $74.5M | $136.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.7M | -$5.5M | $6.7M | -$5.3M | -$8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$718.5M | $301.1M | -$22.1M | $35M | $332.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$113.1M | -$120.1M | -$114.2M | -$121.3M | -$150.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $303M | $915.7M | $879M | $737.7M | |
| Long-Term Debt Repaid | -$644.5M | -$448.4M | -$802.9M | -$805.3M | -$929.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $570K | -$9.4M | -$693K | |
| Cash From Financing | $717.4M | -$270.7M | $1.2M | -$21.5M | -$333.9M | |
| Beginning Cash (CF) | $49.7M | $48.6M | $79M | $58.1M | $71.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.1M | $30.4M | -$20.9M | $13.5M | -$1.2M | |
| Ending Cash (CF) | $48.6M | $79M | $58.1M | $71.2M | $70.1M | |
| Levered Free Cash Flow | -$718.5M | $301.1M | -$22.1M | $35M | $332.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $89.6M | $22.9M | $7.5M | $28.7M | $23.9M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$5M | -$9.5M | -$71K | -$4.4M | $2.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$14.3M | $94M | $70.3M | $87.1M | -$61.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$29M | -$29.1M | -$30.3M | -$36.3M | -$36.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $99M | $185.4M | $196.4M | $164.6M | $416M | |
| Long-Term Debt Repaid | -$41M | -$194.8M | -$230.4M | -$184.2M | -$368.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$257K | -$188K | -$166K | |
| Cash From Financing | $26.8M | -$38.6M | -$61.8M | -$49.7M | $4M | |
| Beginning Cash (CF) | $56.2M | $27.8M | $40.7M | $45.9M | $119.6M | |
| Foreign Exchange Rate Adjustment | -- | $106K | -$221K | -$51K | -$108K | |
| Additions / Reductions | $12.5M | $55.4M | $8.4M | $37.4M | -$57.6M | |
| Ending Cash (CF) | $68.7M | $83.4M | $48.9M | $83.3M | $61.9M | |
| Levered Free Cash Flow | -$14.3M | $94M | $70.3M | $87.1M | -$61.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.3M | $221.9M | $112.9M | $123.4M | $114.3M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$655K | -$3.2M | $7.8M | -$11.6M | -$426K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $24.7M | $116.1M | -$115.6M | $250.9M | -$27.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$123.1M | -$115.2M | -$117.1M | -$136.3M | -$158.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $502.1M | $774.9M | $702.5M | $897.5M | $1.5B | |
| Long-Term Debt Repaid | -$523.1M | -$751M | -$547.5M | -$977.1M | -$1.4B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$7.5M | -$1.9M | -$689K | |
| Cash From Financing | -$25.9M | -$101.5M | $81.7M | -$216.5M | $6.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.2M | $14.6M | -$33.9M | $34.4M | -$21.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $24.7M | $116.1M | -$115.6M | $250.9M | -$27.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.1M | $153.9M | $59.7M | $108.6M | $86.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$6.5M | -$4.2M | -$3.1M | -$9.4M | -$1.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $269.6M | $84.7M | -$8.8M | $207M | -$153.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$91M | -$86.1M | -$89M | -$104M | -$111.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $255M | $726.9M | $513.6M | $532.2M | $1.3B | |
| Long-Term Debt Repaid | -$408.4M | -$711M | -$455.7M | -$627.5M | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$8.1M | -$532K | -$528K | |
| Cash From Financing | -$249.5M | -$80.4M | $45K | -$195M | $145M | |
| Beginning Cash (CF) | $126.8M | $154.1M | $134.2M | $163.5M | $297.2M | |
| Foreign Exchange Rate Adjustment | -- | $106K | -$354K | $1K | $72K | |
| Additions / Reductions | $20.1M | $4.3M | -$8.8M | $12.1M | -$8.2M | |
| Ending Cash (CF) | $146.9M | $158.5M | $125M | $175.6M | $289M | |
| Levered Free Cash Flow | $269.6M | $84.7M | -$8.8M | $207M | -$153.2M | |
Get NMFC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NMFC
Sector
P/E ratio
10.73x
12.02x
PEG ratio
0.71x
0.36x
P/B ratio
0.89x
1.05x
Price / LTM sales
11.19x
2.55x
Growth Metrics
NMFC
Sector
Revenue growth
-8.46%
6.08%
Earnings growth
-18.52%
6.45%
Revenue (5-year growth)
13.64%
5.85%
Earnings forecast
$0.35
$0.56
Profitability
NMFC
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
3.5%
5.27%
Return on assets
3.42%
0.98%
Return on equity
8.32%
9.43%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Jan
29
Balance Sheet
NMFC
Sector
Total cash
$61.9M
$617M
Short term investments
--
$408.4M
Total assets
$3.2B
$4.5B
Long term debt
$2B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 5.45% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.95% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 3.34% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
